Food and Drug Administration (FDA) in May 2022 under the name Mounjaro, to improve blood sugar control in adults with type 2 diabetes but it also showed impressive weight loss results
This phase 3 randomized controlled trial enrolled participants with BMI over 24 kg/m (the obesity threshold in Asian populations) or BMI over 28 kg/m with comorbidities
[60] History and clinical trials [edit] In the 1970s, Jens Juul Holst and Joel Habener began research on GLP-1, initially in relation to duodenal ulcer disease
1 GLP-1 slows down gastric emptying (how fast food moves from your stomach to your intestines) and regulates blood sugar levels
Previous studies of the medication semaglutide found similar results
From there, well cover the typical symptoms of diarrhea caused by Tirzepatide, how long it lasts, and whether certain doses are more likely to trigger it